BioSpace News Archive

Vyriad, Inc. announced that its abstract, In Vivo Generation of Functional CD19 CAR-T Cells Using a Serum-Stable CD3-Targeted Lentiviral Vector, has been selected for an oral presentation at the 65th American Society of Hematology Annual Meeting to be held December 9-12, 2023, in San Diego, California.

NanoString Technologies announced it will present at the Society for Neuroscience annual meeting a large body of new brain research powered by its industry-leading digital spatial profiling and spatial imaging platforms.

Certis Oncology Solutions announced it has been selected as “Overall Immunology Company of the Year” in the third annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services.

Ionis Pharmaceuticals, Inc. announced positive results from an ongoing Phase 2 open-label extension study evaluating the safety and efficacy of its investigational prophylactic medicine, donidalorsen, in patients with hereditary angioedema, a rare and life-threatening genetic disease.

Integrated BioPharma, Inc. reports its financial results for the quarter ended September 30, 2023.

illumiSonics, Inc. announces the publication of a landmark clinical validation study in breast cancer diagnosis.

Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced its operating and financial results and provided a business update for the company’s second fiscal quarter ended September 30

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”) is pleased to announce Corey Giasson

Inogen, Inc. announced that management will present at the following investor conferences.

PurMinds NeuroPharma (“PurMinds™" or the “Company”), a clinical-stage neuroscience company focused on neurological and neurodegenerative disorders and advancing a robust clinical development